A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects
Clinical trial NCT04532567 · COMPLETED
Trial details
- NCT number
- NCT04532567
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2020-12-10
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.